The corona crisis has an impact on our research every day. We understand that you are worried about what this means for you and your research, for example when and how experiments can be restarted, or whether temporary contracts can be extended.
Therefore we organize a webinar specifically aimed at researchers. We would like to update you on everything that is going on and to give you the opportunity to ask the questions you have.
Date webinar for researchers announced: 22 April 20.00 hrs.
In order to be able to include the results of the press conference on 21 April in our update to you, the webinar will be held one day later on Wednesday 22 April at 20.00 hrs. Every researcher will receive an invitation per e-mail with the date and the login details.
Topics for the webinar
Do you have specific topics or questions that you would like to see reflected in the webinar? Let us know via firstname.lastname@example.org.
Related news items
Frank Walboomers 25-years work anniversary at Radboudumc17 September 2020
Frank Walboomers, associate professor at the research group Regenerative Biomaterials at the Dept. of Dentistry (theme Reconstructive & Regenerative Medicine), celebrated his 25th work anniversary at Radboudumc.read more
Tjitske Kleefstra appointed endowed professor of Clinical genetics and psychopathology of rare syndromes17 September 2020
Tjitske Kleefstra has been appointed endowed professor of Clinical genetics and psychopathology of rare syndromes at the department of Neurodevelopmental disorders, with effect from 1 September.read more
Annette Schenck appointed professor of Translational Genetics17 September 2020
Annette Schenck has been appointed professor of Translational Genetics at the department of Neurodevelopmental disorders, with effect from 1 August. The chair will bring together fundamental and translational research in the field of brain developmental disorders.read more
Centuries-old medicine reduces the risk of new cardiovascular disease in heart patients17 September 2020
Colchicine, an anti-inflammatory drug that has been used for gout for centuries, has been shown to prevent cardiovascular disease in patients who have had a heart attack or are suffering from narrowed coronary arteries. Results of the study are published in the New England Journal of Medicine.read more
Radboudumc does large-scale research on systemic sclerosis10 September 2020
In rare diseases, such as systemic sclerosis, it’s often difficult to conduct large-scale research. Rheumatologist Madelon Vonk has managed to follow enough patients with systemic sclerosis for years. The results of her research have been published in BMJ Annal of the Rheumatic Diseases.read more